Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of AVI-5126 in CABG Vein Grafts
NCT00451256Phase 2Terminated
- Sponsor
- Sarepta Therapeutics
- Start
- Mar 2007
- Primary completion
- Nov 2007
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of AVI-5126 in vein graft failure, sponsored by Sarepta Therapeutics. Started Mar 2007; status: terminated.
02
Drugs
AVI-5126
03
Conditions
vein graft failure
Beyond the preview
Go deeper on NCT00451256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451256.